Bausch + Lomb Corporation

BLCO Healthcare Medical Instruments & Supplies

Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.

Revenue
+7.34%
EPS
+222.4%
Free cash flow
+182.5%
Total debt
+2.93%

Quarter to September 2026, against a year earlier

19.94 0.66 −3.20%
Market cap
$7.1B
P/E
0.0×
Fwd P/E
749×
Dividend yield
—
F-score
3/9
Altman Z
0.87
Beneish M
−2.52
Dividend safety
n/a

Bausch + Lomb Corporation (BLCO) Total debt

Alert me on Total debt

Bausch + Lomb Corporation's total debt at the end of fiscal 2025 was $5.1B, up 6.23% from $4.8B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $5.1B. Bausch + Lomb Corporation ranks 4th of 50 Medical Instruments & Supplies companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $5.1B 6.23%
FY2024 $4.8B 4.87%
FY2023 $4.6B 87.27%
FY2022 $2.4B —

Quarterly newest first

Period Total debt Change
Sep 2026 $5.1B (0.39%)
Jun 2026 $5.1B 0.89%
Mar 2026 $5.1B (0.24%)
Dec 2025 $5.1B 2.67%
15 more quarters

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on BLCO